Real-time enrollment status for this major depressive disorder with excessive daytime sleepiness symptoms clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:33 PM UTC
| NCT Number | NCT07484217 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms |
| Phase | PHASE3 |
| Target Enrollment | 508 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Axsome Therapeutics, Inc. |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of August 28, 2026: Clinical trial NCT07484217 is currently recruiting participants. This phase3 study for major depressive disorder with excessive daytime sleepiness symptoms is actively seeking new participants at 40 locations across the United States. The study is sponsored by Axsome Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07484217 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07484217 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.